The Outcomes of Pelvic Fracture Urethral Injuries Stratified by Urethral Injury Severity: A Prospective Multi-institutional Genitourinary Trauma Study (MiGUTS).


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
12 2022
Historique:
received: 06 05 2022
revised: 05 09 2022
accepted: 08 09 2022
pubmed: 25 9 2022
medline: 7 12 2022
entrez: 24 9 2022
Statut: ppublish

Résumé

To determine patient outcomes across a range of pelvic fracture urethral injury (PFUI) severity. PFUI is a devastating consequence of a pelvic fracture. No study has stratified PFUI outcomes based on severity of the urethral distraction injury. Adult male patients with blunt-trauma-related PFUI were followed prospectively for a minimum of six months at 27 US medical centers from 2015-2020. Patients underwent retrograde cystourethroscopy and retrograde urethrography to determine injury severity and were categorized into three groups: (1) major urethral distraction, (2) minor urethral distraction, and (3) partial urethral injury. Major distraction vs minor distraction was determined by the ability to pass a cystoscope retrograde into the bladder. Simple statistics summarized differences between groups. Multi-variable analyses determined odds ratios for obstruction and urethroplasty controlling for urethral injury type, age, and Injury Severity Score. There were 99 patients included, 72(72%) patients had major, 13(13%) had minor, and 14(14%) had partial urethral injuries. The rate of urethral obstruction differed in patients with major (95.8%), minor (84.6%), and partial injuries (50%) (P < 0.001). Urethroplasty was performed in 90% of major, 66.7% of minor, and 35.7% of partial injuries (P < 0.001). In PFUI, a spectrum of severity exists that influences outcomes. While major and minor distraction injuries are associated with a higher risk of developing urethral obstruction and need for urethroplasty, up to 50% of partial PFUI will result in obstruction, and as such need to be closely followed.

Identifiants

pubmed: 36152870
pii: S0090-4295(22)00805-6
doi: 10.1016/j.urology.2022.09.006
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

197-202

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Kiarad Fendereski (K)

University of Utah, Department of Surgery, Salt Lake City, UT. Electronic address: Kiarad.fendereski@hsc.utah.edu.

Benjamin J McCormick (BJ)

University of Utah, Department of Surgery, Salt Lake City, UT.

Sorena Keihani (S)

University of Utah, Department of Surgery, Salt Lake City, UT.

Judith C Hagedorn (JC)

University of Washington and Harborview Medical Center, Seattle, WA.

Bryan Voelzke (B)

Spokane Urology, Spokane, WA.

J Patrick Selph (JP)

University of Alabama, Tuscaloosa, AL.

Bradley D Figler (BD)

University of North Carolina, Chapel Hill, NC.

Niels V Johnsen (NV)

Vanderbilt University Medical Center, Nashville, TN.

Rodrigo Donalisio da Silva (RD)

University of Colorado School of Medicine, Denver Health Medical Center, Aurora, CO.

Joshua A Broghammer (JA)

University of Kansas Medical Center, Kansas, KS.

Shubham Gupta (S)

University of Kentucky College of Medicine, Lexington, KY.

Brandi Miller (B)

Detroit Medical Center, Detroit, MI.

Frank N Burks (FN)

Beaumont Medical Center, Lake Orion, MI.

Jairam R Eswara (JR)

St. Elizabeth's Medical Center, Boston University School of Medicine, Brighten, MA.

E Charles Osterberg (EC)

University of Texas, Dell Medical School, Austin, TX.

Kenneth J Carney (KJ)

Emory University, School of Medicine (Grady Hospital), Atlanta, GA.

Brad A Erickson (BA)

University of Iowa, Hospitals and Clinics, Ames, IA.

Matthew B Gretzer (MB)

University of Arizona Medical Center, Tucson, AZ.

Paul H Chung (PH)

Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA.

Catherine R Harris (CR)

Santa Clara Valley, Medical Center, San Jose, CA.

Gregory P Murphy (GP)

Washington University, School of Medicine, St. Louis, MO.

Paul Rusilko (P)

University of Pittsburgh, Medical Center, Pittsburgh, PA.

Katherine T Anderson (KT)

University of Pittsburgh, Medical Center, Pittsburgh, PA.

Anand Shridharani (A)

University of Tennessee College of Medicine, Chattanooga, TN.

Cooper R Benson (CR)

Tulane School of Medicine, New Orleans, LA.

Amjad Alwaal (A)

Rutgers New Jersey Medical School, New Ark, NJ.

Sarah D Blaschko (SD)

Alameda Health System, Oakland, CA.

Benjamin N Breyer (BN)

University of California, San Francisco, CA.

Maxim McKibben (M)

Carolinas Medical Center, Charlotte, NC.

Ian W Schwartz (IW)

Division of Urology Hennepin County Medical Center, University of Minnesota, Minneapolis, MN.

Jay Simhan (J)

Einstein Healthcare Network, Philapdelphia, PA.

Alex J Vanni (AJ)

Lahey Hospital and Medical Center, Burlington, MA.

Rachel A Moses (RA)

Dartmouth Hitchcock Medical Center, Lebanon, MH.

Jeremy B Myers (JB)

University of Utah, Department of Surgery (Primary Investigator), Salt Lake City, UT.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH